These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26639447)

  • 21. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.
    Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G
    Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a creative functional paradoxical facilitation in juvenile myoclonic epilepsy?
    Senf P; Scheuren L; Holtkamp M
    Epilepsy Behav; 2016 Sep; 62():285-90. PubMed ID: 27521721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic modulation of performance monitoring in Parkinson's disease: An event-related potential study.
    Seer C; Lange F; Loens S; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B
    Sci Rep; 2017 Jan; 7():41222. PubMed ID: 28117420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impulse control disorders in Parkinson disease: a multicenter case--control study.
    Voon V; Sohr M; Lang AE; Potenza MN; Siderowf AD; Whetteckey J; Weintraub D; Wunderlich GR; Stacy M
    Ann Neurol; 2011 Jun; 69(6):986-96. PubMed ID: 21416496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term follow-up of Parkinson's disease patients with impulse control disorders.
    Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
    Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
    Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
    J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Torrance Tests of Creative Thinking and the Rorschach Inkblot Test: relationships between two measures of creativity.
    Baker M
    Percept Mot Skills; 1978 Apr; 46(2):539-47. PubMed ID: 662554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intact action segmentation in Parkinson's disease: Hypothesis testing using a novel computational approach.
    Schiffer AM; Nevado-Holgado AJ; Johnen A; Schönberger AR; Fink GR; Schubotz RI
    Neuropsychologia; 2015 Nov; 78():29-40. PubMed ID: 26432343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
    Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
    Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic medication boosts action-effect binding in Parkinson's disease.
    Moore JW; Schneider SA; Schwingenschuh P; Moretto G; Bhatia KP; Haggard P
    Neuropsychologia; 2010 Mar; 48(4):1125-32. PubMed ID: 20018200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
    Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
    J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.